217330 Stock Chart & Stats
₩3110.00
-₩5.00(-0.16%)
―
--
Day’s Range― - ―
52-Week Range₩2,260.00 - ₩11,200.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)99.36K
Market Cap
₩71.86B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.38
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,129,547
10 Day Avg. Volume69,345
30 Day Avg. Volume99,358
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
217330 FAQ
What was CytoGen, Inc.’s price range in the past 12 months?
CytoGen, Inc. lowest stock price was ₩2260.00 and its highest was ₩11200.00 in the past 12 months.
What is CytoGen, Inc.’s market cap?
CytoGen, Inc.’s market cap is ₩71.86B.
When is CytoGen, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CytoGen, Inc.’s earnings last quarter?
CytoGen, Inc. released its earnings results on May 14, 2026. The company reported -₩55.009 earnings per share for the quarter, missing the consensus estimate of N/A by -₩55.009.
Is CytoGen, Inc. overvalued?
According to Wall Street analysts CytoGen, Inc.’s price is currently Undervalued.
Does CytoGen, Inc. pay dividends?
CytoGen, Inc. does not currently pay dividends.
What is CytoGen, Inc.’s EPS estimate?
CytoGen, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CytoGen, Inc. have?
CytoGen, Inc. has 23,129,547 shares outstanding.
What happened to CytoGen, Inc.’s price movement after its last earnings report?
CytoGen, Inc. reported an EPS of -₩55.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.195%.
Which hedge fund is a major shareholder of CytoGen, Inc.?
Currently, no hedge funds are holding shares in KR:217330
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
iNtRON Biotechnology, Inc.
―
CTC Bio Inc.
―
SunBio, Inc.
―
Genesem, Inc.
―
PROTIA INC.
―